INIS
Radnostix, Inc.
Price Chart
Latest Quote
$0.08
-0.00 (-1.17%)
Current Price
| Previous Close | $0.08 |
| Open | $0.08 |
| Day High | $0.08 |
| Day Low | $0.08 |
| Volume | 10,000 |
Stock Information
| Shares Outstanding | 529.13M |
| Total Debt | $8.79M |
| Cash Equivalents | $1.35M |
| Revenue | $12.21M |
| Net Income | $-2.14M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $40.21M |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $48.13M |
| Sales | $12.21M |
| Income | $-2.14M |
| Book/sh | $0.01 |
| Cash/sh | $0.00 |
| Employees | 44 |
Financial Ratios
| Quick Ratio | 0.59 |
| Current Ratio | 0.88 |
| Debt/Eq | 332.13 |
Returns & Margins
| ROA | -7.92% |
| ROE | -61.36% |
| Gross Margin | 55.87% |
| Operating Margin | -55.07% |
| Profit Margin | -17.55% |
Ownership
| Insider Ownership | 73.47% |
| Institutional Ownership | 0.00% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 5.59 |
| P/S | 3.29 |
| P/B | 15.20 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.07 |
| SMA50 | $0.08 |
| SMA200 | $0.07 |
| RSI | 45.45 |
| ATR | 0.0053 |
| Shares Float | 332.28M |
| Volatility | 1.17 |
| Rel Volume | 0.21 |
Performance History
| Week | +8.57% |
| Month | +8.57% |
| Quarter | -15.56% |
| 6 Months | +8.57% |
| YTD | +26.67% |
| Year | +8.57% |
| 3 Years | +26.67% |
| 5 Years | -45.71% |
| 10 Years | +8.57% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $0.08 | 10,000 |
| 2026-06-24 | $0.08 | 21,000 |
| 2026-06-23 | $0.08 | 500 |
| 2026-06-22 | $0.07 | 1,800 |
| 2026-06-18 | $0.07 | 1,500 |
| 2026-06-17 | $0.07 | 76,300 |
| 2026-06-16 | $0.07 | 7,700 |
| 2026-06-15 | $0.07 | 10,000 |
| 2026-06-12 | $0.07 | 17,900 |
| 2026-06-11 | $0.08 | 240,300 |
| 2026-06-10 | $0.08 | 37,400 |
| 2026-06-09 | $0.07 | 208,000 |
| 2026-06-08 | $0.07 | 150,000 |
| 2026-06-05 | $0.07 | 91,700 |
| 2026-06-04 | $0.08 | 2,000 |
| 2026-06-03 | $0.07 | 1,800 |
| 2026-06-02 | $0.08 | 19,300 |
| 2026-06-01 | $0.07 | 900 |
| 2026-05-29 | $0.08 | 15,000 |
| 2026-05-28 | $0.08 | 22,400 |
| 2026-05-27 | $0.08 | 13,000 |
| 2026-05-26 | $0.07 | 127,200 |
About Radnostix, Inc.
Radnostix, Inc. manufactures and sells nuclear medicine calibration and reference standards, cobalt-60 products, sodium iodide I-131 drug product, and radiochemicals for clinical research and life sciences in the United States and internationally. It operates through five segments: Theranostics Products, Cobalt Products, Calibration & Reference Products, Medical Devices, and Fluorine Products. The Theranostics Products segment produces and distributes Iodine-131 generic drug product and various isotopically pure radiochemicals for medical, industrial, and research applications. The Cobalt Products segment produces cobalt-60 products and services, the fabrication of cobalt-60 sealed sources for radiation therapy, industrial and medical applications, and recycling of expended cobalt-60 sources. The Calibration & Reference Products segment manufactures sources and standards associated with single photon emission computed and positron emission tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. This segment also offers flood sources, dose calibrators, cylinder phantoms, rod sources, line sources, flexible and rigid rulers, spot markers, pen point markers, and various specialty design items. The Medical Devices segment develops EasyFill Automated Capsule System, a robotic lab device. The Fluorine Products segment is involved in the production of small-scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. The company sells its products directly to end users and distributors. The company was formerly known as International Isotopes Inc. and changed its name to Radnostix, Inc. in December 2025. Radnostix, Inc. was incorporated in 1995 and is headquartered in Idaho Falls, Idaho.
đ° Latest News
No news articles available at the moment. Check back later for updates on INIS.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $5,251,207 | $4,888,409 | $4,891,927 | $3,924,142 |
| Cost Of Revenue | $5,251,207 | $4,888,409 | $4,891,927 | $3,924,142 |
| Total Revenue | $13,899,760 | $12,267,385 | $11,181,988 | $9,661,942 |
| Operating Revenue | $13,899,760 | $12,267,385 | $11,181,988 | $9,661,942 |
| Expenses | ||||
| Interest Expense | $328,678 | $331,780 | $613,943 | $791,532 |
| Total Expenses | $13,892,859 | $13,043,684 | $12,384,885 | $10,342,734 |
| Other Income Expense | $207,966 | $160,173 | $2,110,576 | $683,253 |
| Other Non Operating Income Expenses | $207,966 | $160,173 | $2,110,576 | $683,253 |
| Net Non Operating Interest Income Expense | $-206,293 | $-252,890 | $-604,441 | $-791,421 |
| Interest Expense Non Operating | $328,678 | $331,780 | $613,943 | $791,532 |
| Operating Expense | $8,641,652 | $8,155,275 | $7,492,958 | $6,418,592 |
| General And Administrative Expense | $8,030,915 | $7,577,921 | $6,959,242 | $6,146,878 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Net Interest Income | $-206,293 | $-252,890 | $-604,441 | $-791,421 |
| Interest Income | $122,385 | $78,890 | $9,502 | $111 |
| Normalized Income | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Net Income From Continuing And Discontinued Operation | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Total Operating Income As Reported | $6,901 | $-776,299 | $-1,202,897 | $-680,792 |
| Net Income Common Stockholders | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Net Income | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Net Income Including Noncontrolling Interests | $8,574 | $-869,016 | $303,238 | $-788,960 |
| Net Income Continuous Operations | $8,574 | $-869,016 | $303,238 | $-788,960 |
| Pretax Income | $8,574 | $-869,016 | $303,238 | $-788,960 |
| Interest Income Non Operating | $122,385 | $78,890 | $9,502 | $111 |
| Operating Income | $6,901 | $-776,299 | $-1,202,897 | $-680,792 |
| Gross Profit | $8,648,553 | $7,378,976 | $6,290,061 | $5,737,800 |
| Per Share | ||||
| Diluted EPS | $0.00 | $0.00 | $0.00 | $-0.00 |
| Basic EPS | $0.00 | $0.00 | $0.00 | $-0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $738,319 | $-187,142 | $1,288,849 | $607,835 |
| Reconciled Depreciation | $401,067 | $350,094 | $371,668 | $605,263 |
| EBITDA (Bullshit earnings) | $738,319 | $-187,142 | $1,288,849 | $607,835 |
| EBIT | $337,252 | $-537,236 | $917,181 | $2,572 |
| Diluted Average Shares | $522,289,354 | $517,777,847 | $510,794,145 | $477,723,996 |
| Basic Average Shares | $522,289,354 | $517,777,847 | $510,794,145 | $477,723,996 |
| Diluted NI Availto Com Stockholders | $8,574 | $-869,016 | $303,238 | $-902,347 |
| Research And Development | $610,737 | $577,354 | $533,716 | $271,714 |
| Selling General And Administration | $8,030,915 | $7,577,921 | $6,959,242 | $6,146,878 |
| Other Gand A | $4,009,019 | $3,545,766 | $3,568,590 | $3,459,143 |
| Salaries And Wages | $4,021,896 | $4,032,155 | $3,390,652 | $2,687,735 |
| Minority Interests | - | - | $0 | $-113,387 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-410,810 | $-886,088 | $-745,066 | $-2,512,933 |
| Total Assets | $17,160,968 | $16,905,087 | $16,244,596 | $16,327,142 |
| Total Non Current Assets | $12,175,142 | $11,147,603 | $10,503,971 | $13,069,418 |
| Other Non Current Assets | $1,431,710 | $880,752 | $840,049 | $830,752 |
| Goodwill And Other Intangible Assets | $4,757,818 | $4,922,713 | $5,087,608 | $5,243,728 |
| Other Intangible Assets | $3,373,563 | $3,538,458 | $3,703,353 | $3,859,473 |
| Current Assets | $4,985,826 | $5,757,484 | $5,740,625 | $3,257,724 |
| Other Current Assets | $698,030 | $672,934 | $1,023,129 | $1,004,423 |
| Inventory | $820,893 | $927,111 | $744,793 | $924,775 |
| Receivables | $1,521,380 | $1,469,298 | $1,596,886 | $853,675 |
| Accounts Receivable | $1,521,380 | $1,469,298 | $1,596,886 | $853,675 |
| Cash Cash Equivalents And Short Term Investments | $1,945,523 | $2,688,141 | $2,375,817 | $474,851 |
| Cash And Cash Equivalents | $1,945,523 | $2,688,141 | $2,375,817 | $474,851 |
| Allowance For Doubtful Accounts Receivable | - | $0 | $0 | $-18,910 |
| Gross Accounts Receivable | - | $1,469,298 | $1,596,886 | $872,585 |
| Prepaid Assets | - | - | - | $1,004,423 |
| Debt | ||||
| Net Debt | $261,773 | - | - | $1,486,670 |
| Total Debt | $4,298,807 | $4,281,541 | $4,049,915 | $4,463,293 |
| Long Term Debt And Capital Lease Obligation | $3,839,876 | $3,982,243 | $3,269,482 | $3,049,930 |
| Long Term Debt | $1,898,897 | $1,890,732 | $1,034,406 | $677,769 |
| Current Debt And Capital Lease Obligation | $458,931 | $299,298 | $780,433 | $1,413,363 |
| Current Debt | $308,399 | $155,733 | $643,348 | $1,283,752 |
| Other Current Borrowings | $308,399 | $155,733 | $643,348 | $1,283,752 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $12,813,960 | $12,868,462 | $11,902,054 | $13,596,347 |
| Total Non Current Liabilities Net Minority Interest | $9,485,164 | $9,594,706 | $8,387,360 | $8,661,838 |
| Current Liabilities | $3,328,796 | $3,273,756 | $3,514,694 | $4,934,509 |
| Current Deferred Liabilities | $513,317 | $932,682 | $879,365 | $907,953 |
| Payables And Accrued Expenses | $2,356,548 | $2,041,776 | $1,854,896 | $2,613,193 |
| Payables | $861,883 | $559,597 | $382,392 | $1,424,028 |
| Accounts Payable | $861,883 | $559,597 | $382,392 | $1,424,028 |
| Equity | ||||
| Common Stock Equity | $4,347,008 | $4,036,625 | $4,342,542 | $2,730,795 |
| Total Equity Gross Minority Interest | $4,347,008 | $4,036,625 | $4,342,542 | $2,730,795 |
| Stockholders Equity | $4,347,008 | $4,036,625 | $4,342,542 | $2,730,795 |
| Retained Earnings | $-127,321,285 | $-127,329,859 | $-126,460,843 | $-126,764,081 |
| Preferred Securities Outside Stock Equity | $4,063,000 | $4,063,000 | $4,063,000 | $4,719,822 |
| Other | ||||
| Ordinary Shares Number | $523,553,435 | $519,787,870 | $514,889,916 | $502,584,176 |
| Share Issued | $523,553,435 | $519,787,870 | $514,889,916 | $502,584,176 |
| Tangible Book Value | $-410,810 | $-886,088 | $-745,066 | $-2,512,933 |
| Invested Capital | $6,554,304 | $6,083,090 | $6,020,296 | $4,692,316 |
| Working Capital | $1,657,030 | $2,483,728 | $2,225,931 | $-1,676,785 |
| Capital Lease Obligations | $2,091,511 | $2,235,076 | $2,372,161 | $2,501,772 |
| Total Capitalization | $6,245,905 | $5,927,357 | $5,376,948 | $3,408,564 |
| Additional Paid In Capital | $126,432,759 | $126,168,605 | $125,654,486 | $124,469,034 |
| Capital Stock | $5,235,534 | $5,197,879 | $5,148,899 | $5,025,842 |
| Common Stock | $5,235,534 | $5,197,879 | $5,148,899 | $5,025,842 |
| Non Current Accrued Expenses | $37,500 | $75,000 | $112,500 | $0 |
| Long Term Capital Lease Obligation | $1,940,979 | $2,091,511 | $2,235,076 | $2,372,161 |
| Long Term Provisions | $1,544,788 | $1,474,463 | $942,378 | $892,086 |
| Current Deferred Revenue | $513,317 | $932,682 | $879,365 | $907,953 |
| Current Capital Lease Obligation | $150,532 | $143,565 | $137,085 | $129,611 |
| Current Accrued Expenses | $1,494,665 | $1,482,179 | $1,472,504 | $1,189,165 |
| Goodwill | $1,384,255 | $1,384,255 | $1,384,255 | $1,384,255 |
| Net PPE | $5,985,614 | $5,344,138 | $4,576,314 | $6,994,938 |
| Accumulated Depreciation | $-3,122,289 | $-3,033,279 | $-2,872,769 | $-2,968,674 |
| Gross PPE | $9,107,903 | $8,377,417 | $7,449,083 | $9,963,612 |
| Other Properties | $7,500,395 | $7,449,041 | $6,549,021 | $8,502,684 |
| Machinery Furniture Equipment | $1,122,312 | $928,376 | $900,062 | $1,460,928 |
| Land And Improvements | $485,196 | $0 | - | - |
| Properties | $0 | $0 | - | - |
| Finished Goods | - | - | $0 | $0 |
| Work In Process | - | - | $744,793 | $924,775 |
| Raw Materials | - | - | $0 | $0 |
| Minority Interest | - | - | - | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-82,432 | $433,531 | $-1,617,733 | $-367,388 |
| Operating Activities | ||||
| Operating Cash Flow | $638,783 | $582,589 | $-1,497,719 | $-161,914 |
| Cash Flow From Continuing Operating Activities | $638,783 | $582,589 | $-1,497,719 | $-161,914 |
| Operating Gains Losses | $-13,492 | - | $-1,797,978 | - |
| Investing Activities | ||||
| Capital Expenditure | $-721,215 | $-149,058 | $-120,014 | $-205,474 |
| Investing Cash Flow | $-685,215 | $-149,058 | $3,879,986 | $-205,474 |
| Cash Flow From Continuing Investing Activities | $-685,215 | $-149,058 | $3,879,986 | $-205,474 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $11,969 | $8,398 | $76,571 | $18,890 |
| Financing Cash Flow | $-145,228 | $-80,504 | $-472,004 | $-78,701 |
| Cash Flow From Continuing Financing Activities | $-145,228 | $-80,504 | $-472,004 | $-78,701 |
| Net Common Stock Issuance | $11,969 | $8,398 | $76,571 | $18,890 |
| Common Stock Issuance | $11,969 | $8,398 | $76,571 | $18,890 |
| Net Other Financing Charges | - | - | - | $-3,431 |
| Other | ||||
| Repayment Of Debt | $-157,197 | $-88,902 | $-548,575 | $-445,413 |
| Interest Paid Supplemental Data | $162,557 | $163,920 | $54,071 | $75,786 |
| Income Tax Paid Supplemental Data | $10,108 | $10,176 | - | - |
| End Cash Position | $3,377,233 | $3,568,893 | $3,215,866 | $1,305,603 |
| Beginning Cash Position | $3,568,893 | $3,215,866 | $1,305,603 | $1,751,692 |
| Changes In Cash | $-191,660 | $353,027 | $1,910,263 | $-446,089 |
| Net Issuance Payments Of Debt | $-157,197 | $-88,902 | $-548,575 | $-94,160 |
| Net Long Term Debt Issuance | $-157,197 | $-88,902 | $-548,575 | $-94,160 |
| Long Term Debt Payments | $-157,197 | $-88,902 | $-548,575 | $-445,413 |
| Net PPE Purchase And Sale | $-685,215 | $-149,058 | $3,879,986 | $-205,474 |
| Sale Of PPE | $36,000 | $0 | $4,000,000 | $0 |
| Purchase Of PPE | $-721,215 | $-149,058 | $-120,014 | $-205,474 |
| Change In Working Capital | $-22,633 | $588,822 | $-1,051,840 | $-507,124 |
| Change In Other Working Capital | $-419,365 | $53,317 | $-28,588 | $-106,249 |
| Change In Payables And Accrued Expense | $367,692 | $240,040 | $-441,317 | $-499,347 |
| Change In Prepaid Assets | $-25,096 | $350,195 | $-18,706 | $243,007 |
| Change In Inventory | $106,218 | $-182,318 | $179,982 | $-86,988 |
| Change In Receivables | $-52,082 | $127,588 | $-743,211 | $-57,547 |
| Changes In Account Receivables | $-52,082 | $127,588 | $-743,211 | $-57,547 |
| Other Non Cash Items | $65,847 | $48,648 | $324,735 | $444,343 |
| Stock Based Compensation | $199,420 | $464,041 | $352,458 | $84,564 |
| Depreciation Amortization Depletion | $401,067 | $350,094 | $371,668 | $605,263 |
| Depreciation And Amortization | $401,067 | $350,094 | $371,668 | $605,263 |
| Gain Loss On Sale Of PPE | $-13,492 | $0 | $-1,797,978 | $0 |
| Net Income From Continuing Operations | $8,574 | $-869,016 | $303,238 | $-788,960 |
| Depreciation | - | $345,616 | $371,668 | $605,263 |
| Issuance Of Debt | - | - | $0 | $351,253 |
| Long Term Debt Issuance | - | - | $0 | $351,253 |
| Asset Impairment Charge | - | - | - | $18,910 |
Fetched: 2026-02-02